Filtration markers as predictors of ESRD and mortality in southwestern American Indians with type 2 diabetes

American Journal of Kidney Diseases

Volumn 66, Issue 1, 2015, Pages 75-83

  Foster, Meredith C ^a   Inker, Lesley A ^a   Hsu, Chi Yuan ^b   Eckfeldt, John H ^c   Levey, Andrew S ^a   Pavkov, Meda E ^d   Myers, Bryan D ^e   Bennett, Peter H ^f   Kimmel, Paul L ^f   Vasan, Ramachandran S ^g   Coresh, Josef ^h   Nelson, Robert G ^f  

^a TUFTS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e STANFORD UNIVERSITY   (United States)

^f NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^g BOSTON UNIVERSITY   (United States)

^h JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

beta 2 microglobulin (B2M); Beta trace protein (BTP); CKD Biomarkers Consortium; diabetic kidney failure; end stage renal disease (ESRD); filtration markers; glomerular filtration rate (GFR); kidney function; mortality; Pima Indians; type 2 diabetes mellitus

Indexed keywords

BETA 2 MICROGLOBULIN; BETA TRACE PROTEIN; BIOLOGICAL MARKER; CREATININE; CYSTATIN C; IOTALAMIC ACID; UNCLASSIFIED DRUG; ISOMERASE; LIPOCALIN; PROSTAGLANDIN R2 D-ISOMERASE;

ADULT; ALBUMINURIA; AMERICAN INDIAN; ARTICLE; COHORT ANALYSIS; CREATININE CLEARANCE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; ARIZONA; BLOOD; CHRONIC KIDNEY FAILURE; COMORBIDITY; DIABETIC NEPHROPATHY; DISEASE PREDISPOSITION; EPIDEMIOLOGY; ETHNIC GROUP; ETHNOLOGY; GLOMERULUS; HYPERLIPIDEMIA; HYPERTENSION; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY;

ADULT; ARIZONA; BETA 2-MICROGLOBULIN; BIOMARKERS; COMORBIDITY; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; INDIANS, NORTH AMERICAN; INTRAMOLECULAR OXIDOREDUCTASES; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; KIDNEY GLOMERULUS; LIPOCALINS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84937516991     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2015.01.013     Document Type: Article

References (27)

1. A.J. Collins, R.N. Foley, B. Chavers, and et al. US Renal Data System 2013 annual data report Am J Kidney Dis 63 1 suppl 1 2014 e1 e420
2. A.M. Berhane, E.J. Weil, W.C. Knowler, R.G. Nelson, and R.L. Hanson Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death Clin J Am Soc Nephrol 6 10 2011 2444 2451
3. C.S. Fox, K. Matsushita, M. Woodward, and et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis Lancet 380 9854 2012 1662 1673
4. A.S. Krolewski, J.H. Warram, C. Forsblom, and et al. Serum concentration of cystatin C and risk of end-stage renal disease in diabetes Diabetes Care 35 11 2012 2311 2316
5. B.C. Astor, T. Shafi, R.C. Hoogeveen, and et al. Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population Am J Kidney Dis 59 5 2012 653 662
6. M.C. Foster, L.A. Inker, A.S. Levey, and et al. Novel filtration markers as predictors of all-cause and cardiovascular mortality in US adults Am J Kidney Dis 62 1 2013 42 51
7. N.A. Bhavsar, L.J. Appel, J.W. Kusek, and et al. Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD Am J Kidney Dis 58 6 2011 886 893
8. N. Tangri, L.A. Inker, H. Tighiouart, and et al. Filtration markers may have prognostic value independent of glomerular filtration rate J Am Soc Nephrol 23 2 2012 351 359
9. M. Hoke, E. Pernicka, A. Niessner, and et al. Renal function and long-term mortality in patients with asymptomatic carotid atherosclerosis Thromb Haemost 107 1 2011 150 157
10. S. Shinkai, P.H. Chaves, Y. Fujiwara, and et al. Beta2-microglobulin for risk stratification of total mortality in the elderly population: comparison with cystatin C and C-reactive protein Arch Intern Med 168 2 2008 200 206
11. K.S. Spanaus, B. Kollerits, E. Ritz, and et al. Serum creatinine, cystatin C, and beta-trace protein in diagnostic staging and predicting progression of primary nondiabetic chronic kidney disease Clin Chem 56 5 2010 740 749
12. T. Shafi, R.S. Parekh, B.G. Jaar, and et al. Serum beta-trace protein and risk of mortality in incident hemodialysis patients Clin J Am Soc Nephrol 7 9 2012 1435 1445
13. R.G. Nelson, P.H. Bennett, G.J. Beck, and et al. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group N Engl J Med 335 22 1996 1636 1642
14. E.J. Weil, G. Fufaa, L.I. Jones, and et al. Effect of losartan on prevention and progression of early diabetic nephropathy in American Indians with type 2 diabetes Diabetes 62 9 2013 3224 3231
15. A.S. Levey, L.A. Stevens, C.H. Schmid, and et al. A new equation to estimate glomerular filtration rate Ann Intern Med 150 9 2009 604 612
16. L.A. Inker, C.H. Schmid, H. Tighiouart, and et al. Estimating glomerular filtration rate from serum creatinine and cystatin C N Engl J Med 367 1 2012 20 29
17. B.D. Myers, R.G. Nelson, M. Tan, and et al. Progression of overt nephropathy in non-insulin-dependent diabetes Kidney Int 47 6 1995 1781 1789
18. B. Vasquez, E.V. Flock, P.J. Savage, and et al. Sustained reduction of proteinuria in type 2 (non-insulin-dependent) diabetes following diet-induced reduction of hyperglycaemia Diabetologia 26 2 1984 127 133
19. A.L. Chasson, H.J. Grady, and M.A. Stanley Determination of creatinine by means of automatic chemical analysis Tech Bull Regist Med Technol 30 1960 207 212
20. J.P. Fine, and R.J. Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496 509
21. G. Jerums, E. Premaratne, S. Panagiotopoulos, and R.J. MacIsaac The clinical significance of hyperfiltration in diabetes Diabetologia 53 10 2010 2093 2104
22. M.E. Pavkov, W.C. Knowler, R.L. Hanson, and et al. Comparison of serum cystatin C, serum creatinine, measured GFR, and estimated GFR to assess the risk of kidney failure in American Indians with diabetic nephropathy Am J Kidney Dis 62 1 2013 33 41
23. S.P. Juraschek, J. Coresh, L.A. Inker, and et al. Comparison of serum concentrations of beta-trace protein, beta2-microglobulin, cystatin C, and creatinine in the US population Clin J Am Soc Nephrol 8 4 2013 584 592
24. N.C. Munshi, K.C. Anderson, P.L. Bergsagel, and et al. Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2 Blood 117 18 2011 4696 4700
25. C.A. White, S. Ghazan-Shahi, and M.A. Adams β-Trace protein: a marker of GFR and other biological pathways Am J Kidney Dis 65 1 2015 131 146
26. A. Tin, B.C. Astor, E. Boerwinkle, R.C. Hoogeveen, J. Coresh, and W.H. Kao Genome-wide significant locus of beta-trace protein, a novel kidney function biomarker, identified in European and African Americans Nephrol Dial Transplant 28 6 2013 1497 1504
27. S.P. Juraschek, J. Coresh, L.A. Inker, G.P. Rynders, J.H. Eckfeldt, and E. Selvin The effects of freeze-thaw on beta-trace protein and beta2-microglobulin assays after long-term sample storage Clin Biochem 45 9 2012 694 696